169 related articles for article (PubMed ID: 37507024)
1. Identification of Proteomic Biomarkers in Proliferative Verrucous Leukoplakia through Liquid Chromatography With Tandem Mass Spectrometry.
Arroyo E; Pérez Sayáns M; Bravo SB; de Oliveira Barbeiro C; Paravani Palaçon M; Chamorro Petronacci CM; García Vence M; Chantada Vázquez MDP; Blanco Carrión A; Suárez Peñaranda JM; García García A; Gándara Vila P; Días Almeida J; Veríssimo da Costa GC; Sousa Nogueira FC; Medeiros Evaristo JA; de Abreu Pereira D; Rintala M; Salo T; Rautava J; Padín Iruegas E; Oliveira Alves MG; Morandin Ferrisse T; Albergoni da Silveira H; Esquiche León J; Vilela Silva E; Flores IL; Bufalino A
Lab Invest; 2023 Oct; 103(10):100222. PubMed ID: 37507024
[TBL] [Abstract][Full Text] [Related]
2. Potentially malignant disorders revisited-The lichenoid lesion/proliferative verrucous leukoplakia conundrum.
Thomson PJ; Goodson ML; Smith DR
J Oral Pathol Med; 2018 Jul; 47(6):557-565. PubMed ID: 29663518
[TBL] [Abstract][Full Text] [Related]
3. High density of CD8 T cell and immune imbalance of T lymphocytes subsets are associated with proliferative verrucous leukoplakia.
Fernandes D; Barbeiro CO; Palaçon MP; Biancardi MR; Ferrisse TM; Silveira HA; Castilho RM; de Almeida LY; Leon JE; Bufalino A
Immunology; 2023 Jan; 168(1):96-109. PubMed ID: 36056642
[TBL] [Abstract][Full Text] [Related]
4. Segmentation of Oral Leukoplakia (OL) and Proliferative Verrucous Leukoplakia (PVL) Using Artificial Intelligence Techniques.
Alshawwa SZ; Saleh A; Hasan M; Shah MA
Biomed Res Int; 2022; 2022():2363410. PubMed ID: 35909480
[TBL] [Abstract][Full Text] [Related]
5. Global gene expression profile of proliferative verrucous leukoplakia and its underlying biological disease mechanisms.
Farah CS; Shearston K; Turner EC; Vacher M; Fox SA
Oral Oncol; 2024 Apr; 151():106737. PubMed ID: 38408418
[TBL] [Abstract][Full Text] [Related]
6. Predictors of malignant transformation in oral leukoplakia and proliferative verrucous leukoplakia: An observational prospective study including the DNA ploidy status.
Pentenero M; Castagnola P; Castillo FV; Isaevska E; Sutera S; Gandolfo S
Head Neck; 2023 Oct; 45(10):2589-2604. PubMed ID: 37563936
[TBL] [Abstract][Full Text] [Related]
7. [Proliferative verrucous leukoplakia. Report of five cases].
Reichart PA; Philipsen HP
Mund Kiefer Gesichtschir; 2003 May; 7(3):164-70. PubMed ID: 12764683
[TBL] [Abstract][Full Text] [Related]
8. Proliferative verrucous leukoplakia: an elusive disorder.
Parashar P
J Evid Based Dent Pract; 2014 Jun; 14 Suppl():147-53.e1. PubMed ID: 24929599
[TBL] [Abstract][Full Text] [Related]
9. Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens.
Palaçon MP; de Oliveira Barbeiro C; Fernandes D; Biancardi MR; Silveira HA; Ferrisse TM; León JE; Kujan O; Bufalino A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982316
[TBL] [Abstract][Full Text] [Related]
10. Expanded Expression of Toll-Like Receptor 2 in Proliferative Verrucous Leukoplakia.
Koh J; Kurago ZB
Head Neck Pathol; 2019 Dec; 13(4):635-642. PubMed ID: 30888638
[TBL] [Abstract][Full Text] [Related]
11. [Research progress in the diagnosis and management of proliferative verrucous leukoplakia].
Xie YL; Li CY; Jiang SX; Shi WJ; Luo XB; Chen QM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2023 Oct; 58(10):1083-1090. PubMed ID: 37818545
[TBL] [Abstract][Full Text] [Related]
12. Proliferative verrucous leukoplakia: recognition and differentiation from conventional leukoplakia and mimics.
Gillenwater AM; Vigneswaran N; Fatani H; Saintigny P; El-Naggar AK
Head Neck; 2014 Nov; 36(11):1662-8. PubMed ID: 24115154
[TBL] [Abstract][Full Text] [Related]
13. Whole genome DNA methylation and mutational profiles identify novel changes in proliferative verrucous leukoplakia.
Okoturo E; Green D; Clarke K; Liloglou T; Boyd MT; Shaw RJ; Risk JM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jun; 135(6):893-903. PubMed ID: 37088660
[TBL] [Abstract][Full Text] [Related]
14. Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!
Gillenwater AM; Vigneswaran N; Fatani H; Saintigny P; El-Naggar AK
Adv Anat Pathol; 2013 Nov; 20(6):416-23. PubMed ID: 24113312
[TBL] [Abstract][Full Text] [Related]
15. Proliferative verrucous leukoplakia: a case report.
Lopes MA; Pazoki AE; Ord RA
Gen Dent; 2000; 48(6):708-10. PubMed ID: 12004667
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathogenesis of proliferative verrucous leukoplakia: a systematic review.
Okoturo EM; Risk JM; Schache AG; Shaw RJ; Boyd MT
Br J Oral Maxillofac Surg; 2018 Nov; 56(9):780-785. PubMed ID: 30190088
[TBL] [Abstract][Full Text] [Related]
17. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia and proliferative verrucous leukoplakia-A systematic review of retrospective studies.
Celentano A; Glurich I; Borgnakke WS; Farah CS
Oral Dis; 2021 May; 27(4):848-880. PubMed ID: 32306449
[TBL] [Abstract][Full Text] [Related]
18. Involvement of potential pathways in malignant transformation from oral leukoplakia to oral squamous cell carcinoma revealed by proteomic analysis.
Wang Z; Feng X; Liu X; Jiang L; Zeng X; Ji N; Li J; Li L; Chen Q
BMC Genomics; 2009 Aug; 10():383. PubMed ID: 19691830
[TBL] [Abstract][Full Text] [Related]
19. Proliferative verrucous leukoplakia and its tumor markers: Systematic review and meta-analysis.
Rintala M; Vahlberg T; Salo T; Rautava J
Head Neck; 2019 May; 41(5):1499-1507. PubMed ID: 30536498
[TBL] [Abstract][Full Text] [Related]
20. Optimal Management of Proliferative Verrucous Leukoplakia: A Systematic Review of the Literature.
Abadie WM; Partington EJ; Fowler CB; Schmalbach CE
Otolaryngol Head Neck Surg; 2015 Oct; 153(4):504-11. PubMed ID: 26044786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
